ADPT Sale Disclosure
Benzeno Sharon · SEC Form 4 · Filed Jun 30, 2026
Sale
Calculated transaction value
$231.71K
Benzeno Sharon Chief Commercial Ofc Imm Med
Transaction date
Jun 26, 2026
Public filing date
Jun 30, 2026
Filing lag
Filed 4 days later
ADPT daily price context
Close on/before transaction
$20.96
Jun 26, 2026
Close before public filing
$21.4
Jun 29, 2026
Return since public filing
+15.61%
Through Aug 14, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 11,034 shares @ $21
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001780854-26-000008
Filing cohort
Transactions in this filing
Showing 12 of 12
Trades
12
Issuers
1
Estimated value
$4.39M
Buys / sales
0 / 2
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Adaptive Biotechnologies Corp ADPT | Exercise | Jun 29, 2026 | $0 |
| Adaptive Biotechnologies Corp ADPT | Exercise | Jun 29, 2026 | $0 |
| Adaptive Biotechnologies Corp ADPT | Exercise | Jun 29, 2026 | $0 |
| Adaptive Biotechnologies Corp ADPT | Exercise | Jun 29, 2026 | $0 |
| Adaptive Biotechnologies Corp ADPT | Exercise | Jun 29, 2026 | $22.3K |
| Adaptive Biotechnologies Corp ADPT | Exercise | Jun 29, 2026 | $211.03K |
| Adaptive Biotechnologies Corp ADPT | Exercise | Jun 29, 2026 | $99.53K |
| Adaptive Biotechnologies Corp ADPT | Exercise | Jun 29, 2026 | $418.75K |
| Adaptive Biotechnologies Corp ADPT | Sale | Jun 29, 2026 | $3.27M |
| Adaptive Biotechnologies Corp ADPT Current | Sale | Jun 26, 2026 | $231.71K |
| Adaptive Biotechnologies Corp ADPT | Exercise | Jun 26, 2026 | $133.95K |
| Adaptive Biotechnologies Corp ADPT | Exercise | Jun 26, 2026 | $0 |